Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares were up 18.4% during trading on Tuesday . The company traded as high as GBX 1.90 ($0.02) and last traded at GBX 1.90 ($0.02). Approximately 4,184,618 shares were traded during mid-day trading, an increase of 135% from the average daily volume of 1,782,671 shares. The stock had previously closed at GBX 1.60 ($0.02).
Cizzle Biotechnology Stock Performance
The firm has a 50-day moving average price of GBX 1.79 and a two-hundred day moving average price of GBX 1.85. The firm has a market cap of £7.61 million, a price-to-earnings ratio of -192.00 and a beta of 0.38.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Read More
- Five stocks we like better than Cizzle Biotechnology
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Breaking the Mold: 3 Non-Tech Stocks Ready to Surge in 2025
- Consumer Discretionary Stocks Explained
- Your Best Trading Year Starts Here: Top 3 Stocks for 2025 Gains
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Warren Buffett Bets on the Digital Economy With New VeriSign Buy
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
